GILD
2026Q2AMCGilead Sciences Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
Street
Consensus EPS-7.07
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move2.2%
IV front—
P/C full—
P/C front—
Features as of2026-08-03
Run-up
Close—
Ret 5d+0.5%
Ret 10d-1.5%
Ret 20d+1.2%
Ret 30d+6.0%
Actual EPS
-6.75Beat
Estimated EPS-7.07
Actual revenue
7.8B
Surprise %+4.5%
Beat / missBeat
Beat streak 44
Beat streak 88
Reaction
1-day stock reaction+3.1%
Implied vs actual
Implied 2.2%Actual 0.0%
Gap reaction0.0%
Day result+3.1%
Next-day upYes
Realized / IV0.00×
Post tape
Post 5d+0.4%
Post 10d+6.1%
Post volume10.1M
Vol ×10d1.54×
Vol ×20d1.57×
Post range4.6%